[go: up one dir, main page]

ES2104090T3 - Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. - Google Patents

Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2104090T3
ES2104090T3 ES93400811T ES93400811T ES2104090T3 ES 2104090 T3 ES2104090 T3 ES 2104090T3 ES 93400811 T ES93400811 T ES 93400811T ES 93400811 T ES93400811 T ES 93400811T ES 2104090 T3 ES2104090 T3 ES 2104090T3
Authority
ES
Spain
Prior art keywords
flavonas
hidroxi
butil
contain
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93400811T
Other languages
English (en)
Inventor
Yves Rolland
Guy Lewin
Jean-Paul Vilaine
Albert Lenaers
Catherine Thollon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2104090T3 publication Critical patent/ES2104090T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

COMPUESTOS DE FORMULA GENERAL (I): EN LA QUE R REPRESENTA: AL COMO SE DEFINE EN LA DESCRIPCION. MEDICAMENTOS.
ES93400811T 1992-03-31 1993-03-30 Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2104090T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203861A FR2689127B1 (fr) 1992-03-31 1992-03-31 Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
ES2104090T3 true ES2104090T3 (es) 1997-10-01

Family

ID=9428265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93400811T Expired - Lifetime ES2104090T3 (es) 1992-03-31 1993-03-30 Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.

Country Status (13)

Country Link
US (2) US5280024A (es)
EP (1) EP0564350B1 (es)
JP (1) JPH07119221B2 (es)
AT (1) ATE153022T1 (es)
AU (1) AU655106B2 (es)
CA (1) CA2092961A1 (es)
DE (1) DE69310602T2 (es)
DK (1) DK0564350T3 (es)
ES (1) ES2104090T3 (es)
FR (1) FR2689127B1 (es)
GR (1) GR3023938T3 (es)
NZ (1) NZ247287A (es)
ZA (1) ZA932312B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
DE19638515B4 (de) * 1996-09-20 2004-01-15 Grundig Car Intermedia System Gmbh Verfahren und Vorrichtung zur Zuordnung von Nachrichten, insbesondere Verkehrsnachrichten
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
DE10232595A1 (de) * 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
KR100729731B1 (ko) * 2005-07-19 2007-06-20 건국대학교 산학협력단 사람 피부 세포의 세포사멸을 억제하는 활성을 갖는플라보노이드
AU2006275514B2 (en) * 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
KR101444489B1 (ko) 2007-02-01 2014-09-24 리스버로직스 코퍼레이션 심혈관 질환을 예방 및 치료하기 위한 화합물
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
KR101841003B1 (ko) 2009-03-18 2018-03-22 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US9610251B2 (en) 2011-11-01 2017-04-04 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014096965A2 (en) 2012-12-21 2014-06-26 Rvx Therapeutics Inc. Novel heterocyclic compounds as bromodomain inhibitors
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1247909A (fr) * 1955-11-02 1960-12-09 Recordati Lab Farmacologico Dr Procédé de préparation des dérivés d'hydroxychromones
DE1054091B (de) * 1958-05-30 1959-04-02 Chemiewerk Homburg Ag Verfahren zur Herstellung von N-substituierten 2-Phenyl-7-aminoalkoxy-chromonen
DE1418516A1 (de) * 1959-07-28 1968-12-05 Klosa Dipl Chem Dr Josef Verfahren zur Herstellung von Flavon-7-oxyessigsaeureamiden
GB1250388A (es) 1968-11-27 1971-10-20
DE2029658A1 (de) * 1970-06-16 1971-12-23 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof 2 (4 Oxo-4H 1 benzopyran 7 yl) oxy isobutter saure Derivate und Verfahren zur Herstellung derselben
US3816466A (en) * 1971-12-22 1974-06-11 Warner Lambert Co Flavanoid ring systems
JPH02214780A (ja) * 1989-02-14 1990-08-27 San Ei Chem Ind Ltd アントシアン色素の安定化法
JPH035423A (ja) * 1989-06-01 1991-01-11 Ichimaru Pharcos Co Ltd フラボノイド含有過酸化脂質生成抑制剤
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
JPH089610B2 (ja) * 1990-04-06 1996-01-31 キノイン・ジョージセル・エーシュ・ヴェジェーセティ・テルメーケク・ジャーラ・エルテー 置換イソフラボン誘導体の改良された製造方法
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
DE69310602D1 (de) 1997-06-19
US5457103A (en) 1995-10-10
EP0564350B1 (fr) 1997-05-14
ATE153022T1 (de) 1997-05-15
JPH07119221B2 (ja) 1995-12-20
US5280024A (en) 1994-01-18
ZA932312B (en) 1993-10-18
CA2092961A1 (fr) 1993-10-01
AU655106B2 (en) 1994-12-01
NZ247287A (en) 1994-08-26
GR3023938T3 (en) 1997-09-30
DK0564350T3 (da) 1997-12-15
AU3559193A (en) 1993-10-07
JPH0625212A (ja) 1994-02-01
FR2689127A1 (fr) 1993-10-01
FR2689127B1 (fr) 1994-05-06
EP0564350A1 (fr) 1993-10-06
DE69310602T2 (de) 1997-12-18

Similar Documents

Publication Publication Date Title
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ATE180773T1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
NZ331941A (en) Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
YU47204B (sh) Derivati didehidro-vitamina d3
AU1026599A (en) Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
MX9302429A (es) Nuevas tetralonas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
AU6306886A (en) Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
IT1269584B (it) Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 564350

Country of ref document: ES